EverSource Wealth Advisors’s Mereo BioPharma MREO Stock Holding History

EverSource Wealth Advisors’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32	Hold	100	–	–	﹤0.01%	4365
2026 Q1	$33	Sell	100 -317	-76%	-$136	﹤0.01%	4338
2025 Q4	$174	Hold	417	–	–	﹤0.01%	4046
2025 Q3	$859	Sell	417 -53	-11%	-$98	﹤0.01%	3807
2025 Q2	$1.27K	Buy	+470	New	+$1.13K	﹤0.01%	3668

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

EverSource Wealth Advisors's MREO Position: Q2 2026 in Review

EverSource Wealth Advisors held its Mereo BioPharma (MREO) position steady in Q2 2026 at 100 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #4365.

EverSource Wealth Advisors first reported a position in MREO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.27K in Q2 2025. 60 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

EverSource Wealth Advisors held 100 shares of Mereo BioPharma worth $32 as of Q2 2026.
EverSource Wealth Advisors left its Mereo BioPharma share count unchanged in Q2 2026.
Mereo BioPharma made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4365 holding.
EverSource Wealth Advisors first reported a position in Mereo BioPharma in Q2 2025 and has held it in 5 quarters since.
EverSource Wealth Advisors's Mereo BioPharma position peaked at $1.27K in Q2 2025.
60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.